參考文獻 |
1. 李經家,台灣的另一種國病-上泌尿道上皮癌(腎盂癌或輸尿管癌). 高醫醫訊月刊, 2015;34(10): P.16
2. Grayton JE, Miller T, Wilson-Robles H., In vitro evaluation of Selective Inhibitors of Nuclear Export (SINE) drugs KPT-185 and KPT-335 against canine mammary carcinoma and transitional cell carcinoma tumor initiating cells. Vet Comp Oncol, 2017; doi:10.1111/vco.12289.
3. Marvel SJ, Séguin B, Dailey DD, Thamm DH. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder. Vet Comp Oncol, 2017; doi: 10.1111/vco.12286.
4. Harb OA, Haggag R, Ali MM, El Shorbagy S, Abdelbary AM, Abdelaziz LA, Salim RA, Abdel Wahab KM. The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma. J Oncol, 2017;2017:6095205.
5. Jørgensen KR, Høyer S, Sørensen MM, Jensen JB. Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder. ScandJ Urol, 2017; 51(1):85-86.
6. Liu Y, Bui MM, Xu B. Urothelial Carcinoma with squamous differentiation is associated with high tumor stage and pelvic lymph-node metastasis. Cancer Control, 2017; 24(1):78-82.
7. Kim TH, Kim SY, Moon KC, Lee J, Cho JY, Kim SH. Clear Cell Adenocarcinoma of the Urethra in Women: Distinctive MRI Findings for Differentiation From Nonadenocarcinoma and Non-Clear Cell Adenocarcinoma of the Urethra. AJR Am J Roentgenol, 2017;31:1-7.
8. Surveillance, Epidemiology, and End Results Program (SEER), https://seer.cancer.gov/
9. Taiwan Cancer Registry (TCR), http://tcr.cph.ntu.edu.tw/main.php?
Page=A1
10. Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, Rouprêt M. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int, 2009; 104(10):1436-40.
11. Raman JD and Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol, 2007;4(8):432-43.
12. Antoni S, Soerjomataram I, Moore S, Ferlay J, Sitas F, Smith DP, Forman D. The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia. Aust N Z J Public Health, 2014;38(5):455-8.
13. Yehong Han, Dawei Shou, Liang Wen, Jianguang Shi, Jian Ding, Ping Gong, Weihua Gong. Interplay between chronic kidney disease (CKD) and upper tract urothelial carcinomas (UUC): foe or friend. Published online, 2016;7(33): 53951–53958.
14. Saint-Jacques N, Parker L, Brown P, Dummer TJ. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence. Environmental Health, 2014;13:44.
15. Yang MH, Chen KK, Yen CC, Wang WS, Chang YH, Huang WJ, Fan FS, Chiou TJ, Liu JH, Chen PM. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology, 2002;59(5):681-7.
16. Chiang PH, Huang MS, Tsai CJ, Tsai EM, Huang CH, Chiang CP. Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry. Cancer, 1993;71(12):3988-92.
17. Hong YT, Fu LS, Chung LH, Hung SC, Huang YT, Chi CS. Fanconi′s syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs. Pediatr Nephrol, 2006;21(4):577-9.
18. Yang HY, Chen PC, Wang JD. Chinese Herbs Containing Aristolochic Acid Associated with Renal Failure and Urothelial Carcinoma: A Review from Epidemiologic Observations to Causal Inference. BioMed Research International, 2014; 2014:569325.
19. Wu F and Wang T. Risk assessment of upper tract urothelial carcinoma related to aristolochic acid. Cancer Epidemiol Biomarkers Prev, 2013;22(5):812-20.
20. Chen CH, Dickman KG, Huang CY, Moriya M, Shun CT, Tai HC, Huang KH, Wang SM, Lee YJ, Grollman AP, Pu YS. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.Int J Cancer, 2013;133(1):14-20.
21. Cooper GM. The Eukaryotic Cell Cycle. The cell: a molecular approach (2nd ), 2000;Chapter 14.
22. Wang JD and Levin PA. Metabolism, cell growth and the bacterial cell cycle. Nature Reviews Microbiology, 2009;7 (11): 822–7.
23. 崔中和, 劉喜忠, 丁明孝, 細胞生物學(第三版), 2007;388-389.
24. Harvey L, Arnold B, Chris AK, Monty K, Matthew PS, Anthony B, Hidde P, Paul M. Molecular Cell Biology 6th ed, 2008.
25. 吳相鈺, 陳守良, 葛明德. 陳閱增, 普通生物學(第2版), 2009.
26. Morgan D. The Cell Cycle: Principles of Cell Control. New Science Press, 2007;58–60.
27. Anthea M, David L, Jean H, Maryanna QW, Susan J, Jill DW. Cells: Building Blocks of Life. Prentice Hall, 1997;70–4.
28. Yang K, Shrestha S, Zeng H, Karmaus PW, Neale G, Vogel P, Guertin DA, Lamb RF, Chi H. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic programming. Immunity, 2013;39(6):1043-56.
29. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.Circ Res, 1995;76(3):412-7.
30. Hall PA and Watt FM. Stem cells: the generation and maintenance of cellular diversity. Development, 1989;106:619-633.
31. Williams GH and Stoeber K. Cell cycle markers in clinical oncology. Curr Opin Cell Biol, 2007;19: 672-679.
32. Pardee A. G1 events and regulation of cell proliferation. Science, 1989;246 (4930):603–8.
33. Cuddihy AR and O′Connell MJ. Cell-cycle responses to DNA damage in G2. International review of cytology, 2003;222: 99–140.
34. Cimini D, Wan X, Hirel CB, Salmon ED. Aurora Kinase Promotes Turnover of Kinetochore Microtubules to Reduce Chromosome Segregation Errors. Current Biology, 2006;16(17): 1711–8.
35. Burke DJ and Stukenberg PT. Linking kinetochore-microtubule binding to the spindle checkpoint. Developmental Cell, 2008;14 (4): 474–9.
36. Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest, 1995;96(1):491-503.
37. cell cycle, http://grivina.com/diagram/diagram-of-the-cell-cycle/
38. Morgan D. Controlling the Cell Cycle: Introduction, 2007.
39. Evans T, Rosenthal ET, Youngblom J, Distel D, Hunt T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Evans T Cell, 1983;33(2):389-96.
40. Cyclin Expression, https://zh.wikipedia.org/wiki/File:Cyclin_
Expression.svg
41. Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene, 2003;22 (33): 5208–19.
42. Morgan D. The Cell Cycle: Principles of Control. New Science Press, 2007;80(3):141–142.
43. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of Cyclin D/CDK4. Nature, 1993;366(6456):704-7.
44. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human Cyclins. Cell, 1992; 70: 993-1006.
45. Coverley D, Laman H, Laskey RA. Distinct roles for Cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol, 2002;4(7):523–8.
46. Woo RA and Poon RY, Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle, 2003;2 (4): 316–24.
47. Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci, 2002;59 (8): 1317–26.
48. Bruce A, Dennis B, Julian L, Martin R, Keith R, James DW, Nigel O, Kaye HM. Molecular Biology of the Cell. Garland Science 3rd Ed, 1994.
49. Liskay RM. Absence of a measurable G2 phase in two Chinese hamster cell lines. PNAS, 1977;74(4):1622–1625.
50. Smith LD and Ecker RE. The interaction of steroids with Rana pipiens oocytes in the induction of maturation. Developmental Biology, 1971;25(2): 232–247.
51. Masui Y and Markert CL. Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. Journal of Experimental Zoology, 1971;177 (2): 129–145.
52. Al-Khodairy F and Carr AM. DNA repair mutants defining G2 checkpoint pathways in Schizosaccharomyces pombe. The EMBO Journal, 1992;11(4):1343–1350.
53. Raleigh JM and O′Connell MJ. The G2 DNA damage checkpoint targets both Wee1 and Cdc25. Journal of Cell Science, 2000;113(10):1727–1736.
54. Kateřina Bišová, Molecular Mechanisms of Cell Cycleregulation, http://www.alga.cz/en/a-85-molecular-mechanisms-of-cell-cycle-regulation-.html
55. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993;75 (4):817–25.
56. Meng AG and Jiang LL. Induction of G2/M arrest by pseudolaric acid B is mediated by activation of the ATM signaling pathway. Acta Pharmacol Sin, 2009;30(4):442-50
57. Wrana JL. Crossing Smads. Sci STKE, 2000;2000(23): RE1.
58. Derynck R, Zhang Y, Feng XH. Smads: Transcriptional Activators of TGF-β Responses. Cell, 1998;95(6):737–740.
59. Nishimura R, Hata K, Ikeda F, Matsubara T, Yamashita K, Ichida F, Yoneda T. The role of Smads in BMP signaling. Front Biosci, 2003;8:s275-84.
60. Xie F, Zhang Z, van Dam H, Zhang L, Zhou F. Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination. Cells, 2014;3(4):981-93.
61. Bhowmick NA1, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL. TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci U S A, 2003;100(26):15548-1553.
62. Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget, 2015;6(11):9577-91.
63. Chen CS, Tan J, Tien J. Mechanotransduction at cell-matrix and cell-cell contacts. Annu Rev Biomed Eng, 2004;6:275-302.
64. Nagelkerke A, Bussink J, Rowan AE, Span PN. The mechanical microenvironment in cancer: How physics affects tumours.Semin Cancer Biol, 2015;35:62-70.
65. Pavlin D and Gluhak-Heinrich J, Effect of mechanical loading on periodontal cells. Crit Rev Oral Biol Med, 2001;12(5):414-24.
66. Sluysmans S, Vasileva E, Spadaro D, Shah J, Rouaud F, Citi S. The role of apical cell-cell junctions and associated cytoskeleton in mechanotransduction. Biol Cell, 2017;109(4):139-161.
67. Paolo PP and Keely PJ. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci, 2011;124(Pt 8):1195-205.
68. Stavenschi E, Labour MN, Hoey DA. Oscillatory fluid flow induces the osteogenic lineage commitment of mesenchymal stem cells: The effect of shear stress magnitude, frequency, and duration. J Biomech, 2017;(17)30097.
69. Xu T, Xu G, Gu Z, Wu H. Role of endoplasmic reticulum stress pathway in hydrostatic pressure-induced apoptosis in rat mandibular condylar chondrocytes. Mol Cell Biochem, 2017;429(1-2):23-31.
70. Koga T, Shiraki N, Yano S, Suico MA, Morino-Koga S, Sato T, Shuto T, Kume S, Kai H. Mild electrical stimulation with heat shock guides differentiation of embryonic stem cells into Pdx1-expressing cells within the definitive endoderm. BMC Biotechnol, 2017;17(1):14.
71. Liu Y, Yang G, Ji H, Xiang T, Luo E, Zhou S. Synergetic effect of topological cue and periodic mechanical tension-stress on osteogenic differentiation of rat bone mesenchymal stem cells. Colloids Surf B Biointerfaces, 2017;154:1-9.
72. Lien SC, Chang SF, Lee PL, Wei SY, Chang MD, Chang JY, Chiu JJ. Mechanical regulation of cancer cell apoptosis and autophagy: Roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK. Biochim Biophys Acta, 2013;1833(12):3124-33.
73. Lipowsky HH, Kovalcheck S, Zweifach BW. The distribution of blood rheological parameters in the microvasculature of cat mesentery. Circ Res, 1978;43:738 –749.
74. Remuzzi A, Brenner BM, Pata V, Tebaldi G, Mariano R, Belloro A, Remuzzi G. Three-dimensional reconstructed glomerular capillary network: Blood flow distribution and local filtration. Am J Physiol, 1992;263:F562–F572.
75. Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon RF, Glagov S. Carotid bifurcation atherosclerosis: Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res,1983;53:502–514.
76. Gromov P, Gromova I, Olsen CJ, Timmermans-Wielenga V, Talman ML, Serizawa RR, Moreira JM. Tumor interstitial fluid – a treasure trove of cancer biomarkers. Biochim Biophys Acta, 2013;1834(11): 2259–2270.
77. Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res, 1990;50(15):4478–4484.
78. Lee I, Boucher Y, Demhartner TJ, Jain RK. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br J Cancer, 1994;69(3):492–496.
79. Chang SF, Chang CA, Lee DY, Lee PL, Yeh YM, Yeh CR, Cheng CK, Chien S, Chiu JJ. Tumor cell cycle arrest induced by shear stress: Roles of integrins and Smad. Proc Natl Acad Sci U S A, 2008;105(10):3927-3932.
80. Vahidi B, Fatouraee N, Imanparast A, Moghadam AN. A mathematical simulation of the ureter: effects of the model parameters on ureteral pressure/flow relations. J Biomech Eng, 2011;133(3):031004.
81. Rinker KD, Prabhakar V, Truskey GA. Effect of Contact Time and Force on Monocyte Adhesion to Vascular Endothelium. Biophys J, 2001;80(4):1722-32.
82. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol, 2008;4(1):33-41. |